Kastelein Johannes Jacob Pieter bought NAMS
March 26, 2024 · Form 4 insider transaction
Kastelein Johannes Jacob Pieter bought 201,673 shares of NewAmsterdam Pharma Company N.V., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
201,673
Price
N/A
Total value
N/A
RoleOfficer, Director
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateMarch 26, 2024
Filing dateMarch 27, 2024
Shares owned after201,673
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The exercise price of the option is EUR 1.16392.; The Ordinary Shares are held by Futurum B.V. ("Futurum") through NAP PoolCo B.V. ("PoolCo") for the benefit of the Reporting Person. The Reporting Person exercises sole voting and investement control over the Ordinary Shares held by Futurum through PoolCo. PoolCo has no voting or investement control or pecuniary interest in the Ordinary Shares held on behalf of Futurum.